We are live on ! Find out more
LAB icon

Standard BioTools
LAB

119 hedge funds and large institutions have $387M invested in Standard BioTools in 2021 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 32 increasing their positions, 39 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

202% more call options, than puts

Call options by funds: $4.08M | Put options by funds: $1.35M

58% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 12

9% more capital invested

Capital invested by funds: $354M → $387M (+$32.4M)

5% more funds holding

Funds holding: 113 → 119 (+6)

0.16% more ownership

Funds ownership: 76.82% → 76.98% (+0.16%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

18% less repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 39

Holders
119
Holders Change
+6
Holders Change %
+5.31%
% of All Funds
2.08%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
19
Increased
32
Reduced
39
Closed
12
Calls
$4.08M
Puts
$1.35M
Net Calls
+$2.73M
Net Calls Change
+$2.2M

Top Buyers

1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$2.63M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$2.1M
3
N
Nuveen
North Carolina
+$1.92M
4
SAM
Silverback Asset Management
North Carolina
+$1.88M
5
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
+$1.53M

Top Sellers

1
Millennium Management
Millennium Management
New York
-$3.49M
2
CS
Candriam SCA
Luxembourg
-$1.07M
3
HSA
Hussman Strategic Advisors
Maryland
-$887K
4
Jennison Associates
Jennison Associates
New York
-$830K
5
CAM
Connacht Asset Management
New York
-$794K
Name Holding Trade Value Shares
Change 		Change in
Stake
Barclays
76
Barclays
United Kingdom
$205K +$142K +21,535 +224%
VOYA Investment Management
77
VOYA Investment Management
Georgia
$202K – – –
MIM
78
MetLife Investment Management
New Jersey
$197K – – –
Squarepoint
79
Squarepoint
New York
$189K +$189K +28,670 New
Legal & General Group
80
Legal & General Group
United Kingdom
$178K +$94.5K +14,362 +114%
CCA
81
Cruiser Capital Advisors
Connecticut
$165K – – –
Simplex Trading
82
Simplex Trading
Illinois
$161K -$9.21K -1,400 -5%
SEI Investments
83
SEI Investments
Pennsylvania
$131K +$3.88K +590 +3%
ASRS
84
Arizona State Retirement System
Arizona
$128K +$967 +147 +0.8%
FIA
85
FNY Investment Advisers
New York
$118K +$13.2K +2,000 +12%
MHC
86
Meyer Handelman Company
New York
$115K – – –
BNP Paribas Financial Markets
87
BNP Paribas Financial Markets
France
$114K +$74.1K +11,260 +185%
MLICM
88
Metropolitan Life Insurance Company (MetLife)
New York
$113K -$45.4K -6,903 -29%
S
89
SignatureFD
Georgia
$97K – – –
LCS
90
Levin Capital Strategies
New York
$90K – – –
XT
91
XTX Topco
Cayman Islands
$90K +$90.1K +13,690 New
Zurich Cantonal Bank
92
Zurich Cantonal Bank
Switzerland
$89K – – –
TRCT
93
Tower Research Capital (TRC)
New York
$84K +$50.3K +7,648 +149%
Cerity Partners
94
Cerity Partners
New York
$80K – – –
Osaic Holdings
95
Osaic Holdings
Arizona
$79K +$6.41K +975 +9%
Wolverine Trading
96
Wolverine Trading
Illinois
$77K +$79.8K +12,130 New
Teacher Retirement System of Texas
97
Teacher Retirement System of Texas
Texas
$75K +$75.1K +11,413 New
Macquarie Group
98
Macquarie Group
Australia
$74K +$60.7K +9,229 +477%
Ameriprise
99
Ameriprise
Minnesota
$72K -$2.63K -400 -4%
JF
100
Jump Financial
Illinois
$70K -$176K -26,700 -72%
2 3
4
5 6

LAB Hedge Fund Activity: Q3 2021 in Review

119 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q3 2021, worth a combined $387M — up 9.1% from $354M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new LAB positions and 12 closed out — a net gain of 7 holders — while 32 added to existing stakes and 39 trimmed.

The largest buyer was Adage Capital Partners, opening a new position worth an estimated $2.63M. The largest seller was Millennium Management, cutting an estimated $3.49M.

  • 119 institutional investors held Standard BioTools (LAB) as of Q3 2021, up from 113 in Q2 2021.
  • Funds reported $387M of Standard BioTools stock for Q3 2021, up 9.1% quarter-over-quarter.
  • 19 funds opened new Standard BioTools positions in Q3 2021 and 12 closed out, a net change of +7 holders.
  • The largest Standard BioTools buyer in Q3 2021 was Adage Capital Partners, an estimated $2.63M added.
  • The largest Standard BioTools seller in Q3 2021 was Millennium Management, an estimated $3.49M sold.

Based on aggregated 13F filings for Q3 2021.